| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | TL-1-85 | GDSC1000 | pan-cancer | AAC | -0.0011 | 1 |
| mRNA | Sorafenib | FIMM | pan-cancer | AAC | -0.006 | 1 |
| mRNA | Axitinib | FIMM | pan-cancer | AAC | 0.004 | 1 |
| mRNA | pac-1 | GDSC1000 | pan-cancer | AAC | 0.00083 | 1 |
| mRNA | selumetinib:JQ-1 (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.00078 | 1 |
| mRNA | cabozantinib | CTRPv2 | pan-cancer | AAC | -0.00073 | 1 |
| mRNA | Elesclomol | GDSC1000 | pan-cancer | AAC | 0.00064 | 1 |
| mRNA | KIN001-244 | GDSC1000 | pan-cancer | AAC | -0.00055 | 1 |
| mRNA | KH-CB19 | CTRPv2 | pan-cancer | AAC | -0.00066 | 1 |
| mRNA | Bryostatin 1 | GDSC1000 | pan-cancer | AAC | -0.00044 | 1 |